CASHELLE ROSE: Open Payments
NPI 1801172457 · ATLANTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,341 in 75 payments from 9 companies in 2025. Trend: 2023 $746 · 2024 $1,055 · 2025 $1,341
Food & beverage: $1,341
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 31 | $479 |
| Amgen Inc. | 17 | $295 |
| GlaxoSmithKline, LLC. | 10 | $222 |
| E.R. Squibb & Sons, L.L.C. | 5 | $105 |
| Novartis Pharmaceuticals Corporation | 3 | $71 |
| Organon LLC | 4 | $68 |
| Fresenius Kabi USA, LLC | 2 | $44 |
| Janssen Biotech, Inc. | 2 | $44 |
| Octapharma USA, Inc. | 1 | $14 |
Products named: RINVOQ, BENLYSTA, SKYRIZI, OTEZLA, ORENCIA, EVENITY, COSENTYX, TREMFYA.
Industry payments across GA — which companies pay providers there.
